What's new

Human medicines European public assessment report (EPAR): Noxafil, posaconazole, Date of authorisation: 25/10/2005, Revision: 41, Status: Authorised

Human medicines European public assessment report (EPAR): Noxafil, posaconazole, Date of authorisation: 25/10/2005, Revision: 41, Status: Authorised

Apr 23, 2025 - 13:03
 0
Human medicines European public assessment report (EPAR): Noxafil, posaconazole, Date of authorisation: 25/10/2005, Revision: 41, Status: Authorised
Human medicines European public assessment report (EPAR): Noxafil, posaconazole, Date of authorisation: 25/10/2005, Revision: 41, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Pritor, telmisartan, D...

Next Article

Do Beauty Brands Need Sample Sales?

Related Posts

Human medicines European public assessment report (EPAR): Ryzodeg, insulin degludec,insulin aspart, Date of authorisation: 21/01/2013, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 4, 2025  0

Opinion/decision on a Paediatric investigation plan (PIP): Rinvoq, upadacitinib, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Skin and subcutaneous tissue disorders, PIP number: P/0062/2024

Opinion/decision on a Paediatric investigation plan (PI...

Mar 21, 2025  0

New product information wording – Extracts from PRAC re...

Feb 13, 2025  0